The promise of AI in drug discovery is substantial but often exaggerated. For example, at Novartis, researchers are using generative AI to design millions of compounds targeting Huntington’s disease. Despite these advances, significant diseases like Alzheimer’s remain without effective cures, illustrating that technological breakthroughs alone haven’t solved the most pressing health challenges. Meanwhile, caution is advised as even health chatbots have shown risks, reinforcing the complexity of medical innovation.
Back
